drugchannels.net

Avaliação do site drugchannels.net

Drug Channels

 Gerado a 12 de Março de 2026 12:11 PM

Estatísticas desatualizadas? ATUALIZE !

O resultado é de 39/100

Conteúdo SEO

Título

Drug Channels

Cumprimento : 13

Perfeito, o Título contém entre 10 e 70 caracteres.

Descrição

Cumprimento : 0

Mau. Não encontrámos nenhuma Descrição META na sua página.

Palavras-chave

Mau. Não detetámos palavras-chave META na sua página.

Propriedades Og Meta

Esta página não tira vantagens das propriedades Og.

Cabeçalhos

H1 H2 H3 H4 H5 H6
0 21 12 2 0 0
  • [H2] Pages
  • [H2] Tuesday, March 10, 2026
  • [H2] Friday, March 06, 2026
  • [H2] Tuesday, March 03, 2026
  • [H2] Friday, February 27, 2026
  • [H2] Tuesday, February 24, 2026
  • [H2] Friday, February 20, 2026
  • [H2] Wednesday, February 18, 2026
  • [H2] Friday, February 13, 2026
  • [H2] Tuesday, February 10, 2026
  • [H2] Friday, February 06, 2026
  • [H2] Wednesday, February 04, 2026
  • [H2] Tuesday, February 03, 2026
  • [H2] PURCHASE OUR INDUSTRY REPORTS
  • [H2] Sponsors
  • [H2] Search Drug Channels
  • [H2] View Articles by Topic
  • [H2] Popular Recent Posts
  • [H2] View Articles by Date
  • [H2] Drug Channels in the News
  • [H2] INDUSTRY NEWS AND BLOGS
  • [H3] PBM Industry Update 2026: Trends, Challenges, and What’s Ahead (NEW Live Video Webinar)
  • [H3] Time to Evolve: Hubs Flex to New Demands
  • [H3] Preorder Now: DCI’s 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
  • [H3] Beyond DTP 2.0: How Flexible Direct-to-Patient Programs Power Best-In-Class Patient Experiences
  • [H3] Drug Channels News Roundup, February 2026: Mark Cuban on FTC-ESI, What Patients Really Want, QALYs vs. MFN, 340B’s Site of Care Shift, and New Faces at DCI
  • [H3] The State of Patient Access: What Industry Leaders Reveal in a New Survey About Hub Models, Technology, and the Road Ahead
  • [H3] Medicare Part D Pharmacy Networks in 2026: Supermarkets Dominate as Drugstores Stall and Independents Walk Away
  • [H3] The Key to a Better Patient Experience: Improved GTN
  • [H3] Copay Accumulators and Maximizers in 2025: Popular, Profitable, and Problematic
  • [H3] In an Uncertain 340B Environment, Kalderos Offers a Clear Path Forward
  • [H3] The FTC Blows Up Express Scripts’ PBM Model—and Launches the Net Pricing Drug Channel
  • [H3] Latest CMS Data Reveal Six Trends Reshaping U.S. Drug Spending
  • [H4] WHAT YOU WILL LEARN
  • [H4] PRICING OPTIONS

Imagens

Encontrámos 51 imagens nesta página.

48 atributos ALT estão vazios ou em falta. É recomendado adicionar texto alternativo de modo a que os motores de busca identifiquem melhor o conteúdo das suas imagens.

Rácio Texto/HTML

Rácio : 10%

O rácio de texto para código HTML desta página é menor que 15 porcento, o que significa que provavelmente é necessário de adicionar mais conteúdos em forma de texto.

Flash

Perfeito, não foi encontrado conteúdo Flash nesta página.

Iframe

Oh, não, esta página tem Iframes na página, o que significa que o conteúdo destas não pode ser indexado.

Reescrita de URL

Mau. Existem ligações que contêm 'query strings' (sequências de consulta).

Underscores (traços inferiores) nas URLs

Perfeito. Não foram encontrados 'underscores' (traços inferiores) nas suas URLs.

Ligações para a própria página

Encontrámos um total de 421 ligações incluindo 2 ligações a ficheiros

Âncoras Tipo Sumo
ABOUT Internas Passa sumo
INDUSTRY REPORTS Internas Passa sumo
WEBINARS Internas Passa sumo
KEYNOTE SPEAKING Internas Passa sumo
ADVERTISE Internas Passa sumo
SUBSCRIBE / CONTACT Internas Passa sumo
PBM Industry Update 2026: Trends, Challenges, and What’s Ahead (NEW Live Video Webinar) Internas Passa sumo
PBM Industry Update 2026: Externas Passa sumo
Bryce Platt Externas Passa sumo
the Drug Channels studio Externas Passa sumo
The Drug Channels 2026 Video Webinar Series Externas Passa sumo
What You Will Learn Internas Passa sumo
Pricing Options Internas Passa sumo
Important Things To Know Externas Passa sumo
2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers Externas Passa sumo
download this spreadsheet Externas Passa sumo
Click here to request an invoice. Externas Passa sumo
No comments: Internas Passa sumo
Industry Trends Internas Passa sumo
PBMs Internas Passa sumo
Video Internas Passa sumo
Time to Evolve: Hubs Flex to New Demands Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Guest Post Internas Passa sumo
Sponsored Post Internas Passa sumo
Preorder Now: DCI’s 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers Internas Passa sumo
bundle the report purchase with access to DCI’s video webinars Externas Passa sumo
page x of the report overview Externas Passa sumo
No comments: Internas Passa sumo
340B Internas Passa sumo
Benefit Design Internas Passa sumo
Biosimilars Internas Passa sumo
Channel Management Internas Passa sumo
Generic Drugs Internas Passa sumo
Inflation Reduction Act of 2022 Internas Passa sumo
Medicare Part D Internas Passa sumo
Net Pricing Drug Channel Internas Passa sumo
Pharmacy Economics Internas Passa sumo
Specialty Drugs Internas Passa sumo
Beyond DTP 2.0: How Flexible Direct-to-Patient Programs Power Best-In-Class Patient Experiences Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Drug Channels News Roundup, February 2026: Mark Cuban on FTC-ESI, What Patients Really Want, QALYs vs. MFN, 340B’s Site of Care Shift, and New Faces at DCI Internas Passa sumo
Mark Cuban’s $0.02 on the FTC-ESI settlement Internas Passa sumo
What patients want from health insurance Internas Passa sumo
Why the QALY paradox could block MFN Internas Passa sumo
How 340B drives hospital vertical integration Internas Passa sumo
Meet the expanding Drug Channels Institute team! Internas Passa sumo
Join my more than 68,000 LinkedIn followers Externas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Buy-and-Bill Internas Passa sumo
The State of Patient Access: What Industry Leaders Reveal in a New Survey About Hub Models, Technology, and the Road Ahead Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Medicare Part D Pharmacy Networks in 2026: Supermarkets Dominate as Drugstores Stall and Independents Walk Away Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Narrow Networks Internas Passa sumo
Pharmacy Internas Passa sumo
The Key to a Better Patient Experience: Improved GTN Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Copay Accumulators and Maximizers in 2025: Popular, Profitable, and Problematic Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Co-pay Offset Programs Internas Passa sumo
Copay Accumulator Adjustment Internas Passa sumo
In an Uncertain 340B Environment, Kalderos Offers a Clear Path Forward Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
The FTC Blows Up Express Scripts’ PBM Model—and Launches the Net Pricing Drug Channel Internas Passa sumo
Drug Channels Outlook 2026 webinar Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Enforcement Internas Passa sumo
Gross-to-Net Bubble Internas Passa sumo
Group Purchasing Organizations (GPOs) Internas Passa sumo
Latest CMS Data Reveal Six Trends Reshaping U.S. Drug Spending Internas Passa sumo
Read more » Internas Passa sumo
No comments: Internas Passa sumo
Costs/Reimbursement Internas Passa sumo
Health Insurance Exchanges Internas Passa sumo
Older Posts Internas Passa sumo
Home Internas Passa sumo
Drug Channels Institute Externas Passa sumo
@DrugChannels Externas Passa sumo
The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments Internas Passa sumo
2026 Internas Passa sumo
March 2026 Internas Passa sumo
February 2026 Internas Passa sumo
January 2026 Internas Passa sumo
2025 Internas Passa sumo
December 2025 Internas Passa sumo
November 2025 Internas Passa sumo
October 2025 Internas Passa sumo
September 2025 Internas Passa sumo
August 2025 Internas Passa sumo
July 2025 Internas Passa sumo
June 2025 Internas Passa sumo
May 2025 Internas Passa sumo
April 2025 Internas Passa sumo
March 2025 Internas Passa sumo
February 2025 Internas Passa sumo
January 2025 Internas Passa sumo
2024 Internas Passa sumo
December 2024 Internas Passa sumo
November 2024 Internas Passa sumo
October 2024 Internas Passa sumo
September 2024 Internas Passa sumo
August 2024 Internas Passa sumo
July 2024 Internas Passa sumo
June 2024 Internas Passa sumo
May 2024 Internas Passa sumo
April 2024 Internas Passa sumo
March 2024 Internas Passa sumo
February 2024 Internas Passa sumo
January 2024 Internas Passa sumo
2023 Internas Passa sumo
December 2023 Internas Passa sumo
November 2023 Internas Passa sumo
October 2023 Internas Passa sumo
September 2023 Internas Passa sumo
August 2023 Internas Passa sumo
July 2023 Internas Passa sumo
June 2023 Internas Passa sumo
May 2023 Internas Passa sumo
April 2023 Internas Passa sumo
March 2023 Internas Passa sumo
February 2023 Internas Passa sumo
January 2023 Internas Passa sumo
2022 Internas Passa sumo
December 2022 Internas Passa sumo
November 2022 Internas Passa sumo
October 2022 Internas Passa sumo
September 2022 Internas Passa sumo
August 2022 Internas Passa sumo
July 2022 Internas Passa sumo
June 2022 Internas Passa sumo
May 2022 Internas Passa sumo
April 2022 Internas Passa sumo
March 2022 Internas Passa sumo
February 2022 Internas Passa sumo
January 2022 Internas Passa sumo
2021 Internas Passa sumo
December 2021 Internas Passa sumo
November 2021 Internas Passa sumo
October 2021 Internas Passa sumo
September 2021 Internas Passa sumo
August 2021 Internas Passa sumo
July 2021 Internas Passa sumo
June 2021 Internas Passa sumo
May 2021 Internas Passa sumo
April 2021 Internas Passa sumo
March 2021 Internas Passa sumo
February 2021 Internas Passa sumo
January 2021 Internas Passa sumo
2020 Internas Passa sumo
December 2020 Internas Passa sumo
November 2020 Internas Passa sumo
October 2020 Internas Passa sumo
September 2020 Internas Passa sumo
August 2020 Internas Passa sumo
July 2020 Internas Passa sumo
June 2020 Internas Passa sumo
May 2020 Internas Passa sumo
April 2020 Internas Passa sumo
March 2020 Internas Passa sumo
February 2020 Internas Passa sumo
January 2020 Internas Passa sumo
2019 Internas Passa sumo
December 2019 Internas Passa sumo
November 2019 Internas Passa sumo
October 2019 Internas Passa sumo
September 2019 Internas Passa sumo
August 2019 Internas Passa sumo
July 2019 Internas Passa sumo
June 2019 Internas Passa sumo
May 2019 Internas Passa sumo
April 2019 Internas Passa sumo
March 2019 Internas Passa sumo
February 2019 Internas Passa sumo
January 2019 Internas Passa sumo
2018 Internas Passa sumo
December 2018 Internas Passa sumo
November 2018 Internas Passa sumo
October 2018 Internas Passa sumo
September 2018 Internas Passa sumo
August 2018 Internas Passa sumo
July 2018 Internas Passa sumo
June 2018 Internas Passa sumo
May 2018 Internas Passa sumo
April 2018 Internas Passa sumo
March 2018 Internas Passa sumo
February 2018 Internas Passa sumo
January 2018 Internas Passa sumo
2017 Internas Passa sumo
December 2017 Internas Passa sumo
November 2017 Internas Passa sumo
October 2017 Internas Passa sumo
September 2017 Internas Passa sumo
August 2017 Internas Passa sumo
July 2017 Internas Passa sumo
June 2017 Internas Passa sumo
May 2017 Internas Passa sumo
April 2017 Internas Passa sumo
March 2017 Internas Passa sumo
February 2017 Internas Passa sumo
January 2017 Internas Passa sumo
2016 Internas Passa sumo
December 2016 Internas Passa sumo
November 2016 Internas Passa sumo
October 2016 Internas Passa sumo
September 2016 Internas Passa sumo
August 2016 Internas Passa sumo
July 2016 Internas Passa sumo
June 2016 Internas Passa sumo
May 2016 Internas Passa sumo
April 2016 Internas Passa sumo
March 2016 Internas Passa sumo
February 2016 Internas Passa sumo
January 2016 Internas Passa sumo
2015 Internas Passa sumo
December 2015 Internas Passa sumo
November 2015 Internas Passa sumo
October 2015 Internas Passa sumo
September 2015 Internas Passa sumo
August 2015 Internas Passa sumo
July 2015 Internas Passa sumo
June 2015 Internas Passa sumo
May 2015 Internas Passa sumo
April 2015 Internas Passa sumo
March 2015 Internas Passa sumo
February 2015 Internas Passa sumo
January 2015 Internas Passa sumo
2014 Internas Passa sumo
December 2014 Internas Passa sumo
November 2014 Internas Passa sumo
October 2014 Internas Passa sumo
September 2014 Internas Passa sumo
August 2014 Internas Passa sumo
July 2014 Internas Passa sumo
June 2014 Internas Passa sumo
May 2014 Internas Passa sumo
April 2014 Internas Passa sumo
March 2014 Internas Passa sumo
February 2014 Internas Passa sumo
January 2014 Internas Passa sumo
2013 Internas Passa sumo
December 2013 Internas Passa sumo
November 2013 Internas Passa sumo
October 2013 Internas Passa sumo
September 2013 Internas Passa sumo
August 2013 Internas Passa sumo
July 2013 Internas Passa sumo
June 2013 Internas Passa sumo
May 2013 Internas Passa sumo
April 2013 Internas Passa sumo
March 2013 Internas Passa sumo
February 2013 Internas Passa sumo
January 2013 Internas Passa sumo
2012 Internas Passa sumo
December 2012 Internas Passa sumo
November 2012 Internas Passa sumo
October 2012 Internas Passa sumo
September 2012 Internas Passa sumo
August 2012 Internas Passa sumo
July 2012 Internas Passa sumo
June 2012 Internas Passa sumo
May 2012 Internas Passa sumo
April 2012 Internas Passa sumo
March 2012 Internas Passa sumo
February 2012 Internas Passa sumo
January 2012 Internas Passa sumo
2011 Internas Passa sumo
December 2011 Internas Passa sumo
November 2011 Internas Passa sumo
October 2011 Internas Passa sumo
September 2011 Internas Passa sumo
August 2011 Internas Passa sumo
July 2011 Internas Passa sumo
June 2011 Internas Passa sumo
May 2011 Internas Passa sumo
April 2011 Internas Passa sumo
March 2011 Internas Passa sumo
February 2011 Internas Passa sumo
January 2011 Internas Passa sumo
2010 Internas Passa sumo
December 2010 Internas Passa sumo
November 2010 Internas Passa sumo
October 2010 Internas Passa sumo
September 2010 Internas Passa sumo
August 2010 Internas Passa sumo
July 2010 Internas Passa sumo
June 2010 Internas Passa sumo
May 2010 Internas Passa sumo
April 2010 Internas Passa sumo
March 2010 Internas Passa sumo
February 2010 Internas Passa sumo
January 2010 Internas Passa sumo
2009 Internas Passa sumo
December 2009 Internas Passa sumo
November 2009 Internas Passa sumo
October 2009 Internas Passa sumo
September 2009 Internas Passa sumo
July 2009 Internas Passa sumo
June 2009 Internas Passa sumo
May 2009 Internas Passa sumo
April 2009 Internas Passa sumo
March 2009 Internas Passa sumo
February 2009 Internas Passa sumo
January 2009 Internas Passa sumo
2008 Internas Passa sumo
December 2008 Internas Passa sumo
November 2008 Internas Passa sumo
October 2008 Internas Passa sumo
September 2008 Internas Passa sumo
August 2008 Internas Passa sumo
July 2008 Internas Passa sumo
June 2008 Internas Passa sumo
May 2008 Internas Passa sumo
April 2008 Internas Passa sumo
March 2008 Internas Passa sumo
February 2008 Internas Passa sumo
January 2008 Internas Passa sumo
2007 Internas Passa sumo
December 2007 Internas Passa sumo
November 2007 Internas Passa sumo
October 2007 Internas Passa sumo
September 2007 Internas Passa sumo
August 2007 Internas Passa sumo
July 2007 Internas Passa sumo
June 2007 Internas Passa sumo
May 2007 Internas Passa sumo
April 2007 Internas Passa sumo
March 2007 Internas Passa sumo
February 2007 Internas Passa sumo
January 2007 Internas Passa sumo
2006 Internas Passa sumo
December 2006 Internas Passa sumo
November 2006 Internas Passa sumo
October 2006 Internas Passa sumo
September 2006 Internas Passa sumo
August 2006 Internas Passa sumo
July 2006 Internas Passa sumo
June 2006 Internas Passa sumo
May 2006 Internas Passa sumo
Trump administration revives effort to launch pilot initiative reworking drug discount program Externas Passa sumo
FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded access Externas Passa sumo
Preparations for IRA’s Destruction of Part B Margins Could Begin in 2026 Externas Passa sumo
340B Transparency Requirements Will Begin Restraining Spending Growth in 2026 Externas Passa sumo
How Will Plans Cope As Pharma Net Pricing Trend Deflates ‘Gross-To-Net Bubble’? Externas Passa sumo
IRA Will Slow 340B Growth in 2026, Predicts Drug Channels’ Adam Fein Externas Passa sumo
Why a Budding Drug-Price Revolution Isn’t Quite What It Seems Externas Passa sumo
Cigna ‘Rebate-Free’ Pharmacy Model Will Test Employer Reliance On Revenue Stream Externas Passa sumo
Mark Cuban is trying to shake up biosimilar pricing with a version of J&J’s best-selling Stelara drug Externas Passa sumo
Cigna Plunges on Expected Pressure in Pharmacy Benefit Segment Externas Passa sumo
Cigna’s End to Drug Rebates Spurs Questions on Premiums, Impact Externas Passa sumo
The Next Phase of Vertical Integration - Wholesalers Join the Game Externas Passa sumo
Trump Wants to Overhaul Drug Sales. A Company Tied to His Son Stands to Benefit. Externas Passa sumo
What Options Do Retail Pharmacies Have to Become Profitable? Externas Passa sumo
PBMs No Longer Profit From Rebates But Plans Benefit; Should Sponsors Push More For Reform? Externas Passa sumo
Vertical Integration Has Helped Upend Traditional PBM Model, Form ‘New Profit Drivers’ Externas Passa sumo
Employers Get Big Drug Discounts Through a Program for Poor Hospital Patients Externas Passa sumo
Drugmakers cut some list prices, shrinking room for rebates in cancer, asthma and diabetes Externas Passa sumo
IRA Rollout, Regulatory Gaps May Drive Major 340B Reforms in 2025, Says Adam Fein of Drug Channels Externas Passa sumo
Drug Channels Predicts More Wholesaler Vertical Integration Over Next Couple of Years Externas Passa sumo
As Luigi Mangione Is Lionized, Will Hate for Insurers Produce Any Change? Externas Passa sumo
Is The Time Right For Congressional Action On 340B? Externas Passa sumo
Lawmakers want FTC to probe big PBMs over private-label biosimilar deals Externas Passa sumo
Federal agency opposes J&J's new 340B discount model, promises to take 'actions as warranted' Externas Passa sumo
The Next 340B Battle: Discount Duplication With Medicare Negotiated Prices Externas Passa sumo
The Anti-Competitive Middlemen Harming Pharmacies And Patients Externas Passa sumo
IRA Could ‘Crush the 340B Margin,’ Force Transparency into Program, Says Adam Fein of Drug Channels Externas Passa sumo
The Opaque Industry Secretly Inflating Prices for Prescription Drugs Externas Passa sumo
Navigating the Inflation Reduction Act's Impact on Drug Pricing and Health Care Externas Passa sumo
Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene? Externas Passa sumo
Boehringer Ingelheim to cap asthma inhaler out-of-pocket costs at $35 Externas Passa sumo
Drug Channel Entities Are Undergoing Raft of Changes Externas Passa sumo
CVS Removes Humira From Formulary — But the Fine Print Is Key Externas Passa sumo
CVS Plans to Overhaul How Much Drugs Cost Externas Passa sumo
Amazon Once Inspired Fear in the Health-Care Industry. No Longer Externas Passa sumo
Why Your Neighborhood Pharmacy Isn’t So Friendly Anymore Externas Passa sumo
Rite Aid Bankruptcy Follows Years of PBM Misadventure Externas Passa sumo
What CVS Stands to Gain by Setting Up Biosimilar Subsidiary Cordavis Externas Passa sumo
Ohio senator says Medicare drug cost negotiations will save money. Others aren't so sure Externas Passa sumo
Drug Benefit Firms Devise New Fees That Go to Them, Not Clients Externas Passa sumo
CVS Health Dives As Blue Shield Of California Taps Mark Cuban, Amazon In Challenge To PBM Model Externas Passa sumo
A Big Health Insurer Is Ripping Up the Playbook on Drug Pricing Externas Passa sumo
Patients already paying price for PBMs diverting copay cash meant for needy Externas Passa sumo
PBMs Keep New Biosimilars on Equal Footing With Best-Selling Humira Externas Passa sumo
Accumulators, Maximizers, Alternative Funding Models Contribute to ‘Doom Loop of Specialty Drug Benefits’ Externas Passa sumo
How to Beat the Rising Cost of Prescription Drugs Externas Passa sumo
Average salaries for retail pharmacists grows for first time in three years Externas Passa sumo
Coherus works with Mark Cuban to sell biosimilar Humira at steep discounts Externas Passa sumo
The Healthcare World According to Fein Externas Passa sumo
Drug Middlemen Accused of Price Fixing by Ohio Attorney General Externas Passa sumo
Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines Externas Passa sumo
A Softbank-backed pharmacy startup is working to tackle a $300-billion-a-year prescription drug crisis Externas Passa sumo
Tackling cancer while battling the insurance system Externas Passa sumo
'It is legal extortion': Diabetics pay steep price for insulin as rebates drive up costs Externas Passa sumo
Endpoints Externas Passa sumo
Lilly warns of impurity risk in certain compounded forms of Mounjaro and Zepbound Externas Passa sumo
RxTrace Externas Passa sumo
The 12-Digit Revolution: Understanding FDA’s National Drug Code Transformation Externas Passa sumo
PR Newswire: Health Insurance Externas Passa sumo
Advantmed Appoints Vijay Prabhakar as Chief Revenue Officer Externas Passa sumo
The Catalyst (PhRMA) Externas Passa sumo
Leadership in biopharmaceutical R&D provides U.S. patients the greatest access to innovative medicines Externas Passa sumo
STAT Externas Passa sumo
STAT+: FDA approves leucovorin for rare disorder without trial data Externas Passa sumo
Biosimilars Review & Report Externas Passa sumo
Two Leaders’ Views on National PBM Reform: Biosimilar and ERISA Benefits Externas Passa sumo
PCMA Externas Passa sumo
Wyoming Weekly Update 3.6.26 Externas Passa sumo
Payer Perspectives Externas Passa sumo
HealthIntel Weekly: Medicare Advantage Benefits Drops Sharply in 2026 Externas Passa sumo
Blog - Health Business Group Externas Passa sumo
Tariffs Are Good?! Why U.S. Drug Manufacturers Are the Real Winners Externas Passa sumo
Privacy Policy Externas Passa sumo

Palavras-chave SEO

Núvem de palavras-chave

pbms drug adam industry read february report more from fein

Consistência das Palavras-chave

Palavra-chave Conteúdo Título Palavras-chave Descrição Cabeçalhos
drug 33
more 23
february 21
industry 20
from 18

Usabilidade

Url

Domínio : drugchannels.net

Cumprimento : 16

Favicon

Ótimo, o site tem um favicon.

Facilidade de Impressão

Não encontrámos CSS apropriado para impressão.

Língua

Não foi declarada nenhuma língua para este site.

Dublin Core

Esta página não tira vantagens do Dublin Core.

Documento

Tipo de Documento

HTML 5

Codificação

Perfeito. O conjunto de caracteres UTF-8 está declarado.

Validação W3C

Erros : 0

Avisos : 0

Privacidade do Email

Aviso! No mínimo, foi encontrado um endereço de email sob a forma de texto. Isto é um convite para que spammers entupam a caixa de correio deste endereço.

HTML obsoleto

Fantástico! Não detetámos etiquetas HTML obsoletas.

Dicas de Velocidade

Atenção! Existem tabelas dentro de outras tabelas em HTML.
Oh não, o site usa estilos CSS nas etiquetas HTML.
Boa, o site usa poucos ficheiros CSS.
Oh, não! O site utiliza demasiados ficheiros JavaScript (mais que 6).
Perfeito, o site tira vantagens da compressão gzip.

Dispositivos Móveis

Otimização para dispositivos móveis

Icon Apple
Meta Viewport Tag
Conteúdo Flash

Otimização

XML Sitemap

Perfeito, o site tem um mapa XML do site (sitemap).

https://www.drugchannels.net/sitemap.xml

Robots.txt

https://drugchannels.net/robots.txt

Perfeito, o seu site tem um ficheiro robots.txt.

Analytics

Perfeito, o site tem uma ferramenta analítica para a análise de atividade.

   Google Analytics

PageSpeed Insights

Dispositivo
Categorias

Free SEO Testing Tool

Free SEO Testing Tool é uma ferramenta gratuita que o ajuda a avaliar o seu site